Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-04 Sale |
2023-04-06 4:37 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director |
39,228 | $1.85 | $72,572 | 188,779 (Direct) |
View |
| 2023-03-13 Purchase |
2023-03-14 8:39 pm |
Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
85,987 | $0.99966 | $85,958 | 5,300,087 (Indirect) |
View |
| 2023-01-09 Sale |
2023-01-11 8:33 pm |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
9,285 | $1.111 | $10,316 | 103,417 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 8:32 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
45,070 | $1.111 | $50,075 | 228,007 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 8:30 pm |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
14,096 | $1.111 | $15,661 | 66,018 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 8:29 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer |
16,634 | $1.111 | $18,481 | 110,082 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-11 8:57 pm |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
8,383 | $6.883 | $57,700 | 85,202 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-11 8:57 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
37,294 | $6.883 | $256,696 | 185,577 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-11 8:56 pm |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
12,817 | $6.883 | $88,220 | 52,614 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-11 8:55 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
9,673 | $6.883 | $66,580 | 64,216 (Direct) |
View |
| 2021-11-12 Sale |
2021-11-16 7:57 pm |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,900,000 | $8.38 | $15,922,000 | 4,698,661 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-03 Other |
2023-05-05 4:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Concentra Biosciences LLC 10% Owner |
10,000 | $0.97377 | 20,000 (Direct) |
View |
| 2023-05-03 Equity Swap |
2023-05-05 4:37 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner |
5,300,087 | $1.85 | 20,000 (Indirect) |
View |
| 2023-05-03 Other |
2023-05-05 4:37 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner |
10,000 | $9,738 | 20,000 (Indirect) |
View |
Ownership |
2023-05-05 4:35 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Concentra Biosciences LLC Concentra Merger Sub Inc. 10% Owner |
0 | $0 | 36,367,727 (Indirect) |
View |
| 2023-05-03 Equity Swap |
2023-05-04 07:44 am |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director |
188,778 | $0 | 1 (Direct) |
View |
| 2023-05-03 Equity Swap |
2023-05-04 07:44 am |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
5,000 | $0 | 0 (Direct) |
View |
| 2023-05-03 Equity Swap |
2023-05-04 07:44 am |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Kamen Robert Director |
94,850 | $0 | 0 (Direct) |
View |
| 2023-05-03 Equity Swap |
2023-05-04 07:43 am |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C President, CFO and Treasurer |
66,018 | $0 | 0 (Direct) |
View |
Ownership |
2023-03-14 8:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
0 | $0 | 5,214,100 (Indirect) |
View |
| 2022-08-01 Option Award |
2022-08-03 8:29 pm |
N/A 2032-08-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer |
60,000 | $0 | 166,716 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:08 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:08 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Raythatha Jigar Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:07 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:06 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Kamen Robert Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:05 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Iannone Robert Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:03 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Higgons John Duncan Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:02 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Diaz Luis Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-02-01 Option Award(A) |
2022-03-17 8:50 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:38 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
127,500 | $0 | 191,716 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:38 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer |
82,500 | $0 | 135,114 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:37 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
262,500 | $0 | 448,077 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:36 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | Trehu Elizabeth Chief Medical Officer |
82,500 | $0 | 167,702 (Direct) |
View |
| 2021-09-15 Other |
2021-09-17 4:15 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,750,000 | $0 | 8,348,661 (Direct) |
View |